This is in reference to our earlier communication dated September 19, 2023, regarding the establishment of a 50:50 joint venture (JV) Company in Tanzania to provide diagnostic and healthcare services directly to customers. We wish to inform you that today i.e. December 03, 2024, the Company has made another tranche of equity Investment of USD 100,000 (equivalent to INR 84,90,000) in Thyrocare Laboratories (Tanzania) Limited.